Zydus Lifesciences Limited (ZYDUSLIFE) announces USFDA inspection conclusion at Ahmedabad plant with one observation, no data integrity issues.
Lupin Limited (NSE: LUPIN) announced receiving tentative approval from the U.S. FDA for its Apixaban Oral Suspension 1.25mg/mL.
Morepen Laboratories Limited (MOREPENLAB) submits its first U.S. ANDA for Sitagliptin Tablets, enhancing its CDMO capabilities.
Sun Pharma secures global licensing for Lerodalcibep, a PCSK9 inhibitor, to expand its Innovative Medicines portfolio and address cardiovascular care needs.
Zydus Lifesciences Limited (ZYDUSLIFE) announces USFDA inspection of pharmacovigilance and post marketing system concludes with nil observations.
Jagsonpal Pharmaceuticals Ltd. acquires Wellness Portfolio of Group Pharmaceuticals, enhancing its pharmaceutical portfolio and market reach.
Indegene Limited (INDGN) highlights at Digital Summit 2026: Leaders focus on operationalizing AI for enterprise outcomes.
